Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email Placebo-controlled randomized trials of anticoagulants in acute CVT Einhaupl et al trial, 1991, intravenous heparin versus placebo Heparin versus placebo Outcome at three months Heparin group Total recovery 8 (80 percent) Residual motor deficit 2 (20 percent) Placebo group Total recovery 1 (10 percent) Minor residual deficit 6 (60 percent) Deaths 3 (30 percent) De Bruijn et al trial, 1999, subcutaneous nadroparin versus placebo Outcome difference Nadroparin Placebo Risk At three weeks Deaths 2 4 BI score <15 4 3 Death or BI <15 6 (20 percent) 7 (24 percent) 4 percent (-25 a 17) At 12 weeks Deaths 2 4 Dependent (R 3-5) 2 2 Death or dependent (R 3-5) 4 (13 percent) +6 (21 percent) 7 percent (-26 a 12) BI: Barthel Index; R: modified Rankin scale score.